[Edaily Reporter Kwon Oh Seok ] SD BIOTECHNOLOGIES CO., LTD.(217480)announced on the 27th that it has decided to consolidate five common shares into one. As a result, the par value per common share will increase from 200 won to 1,000 won, and the total number of issued shares will decrease from 109,733,141 to 21,946,628. The company explained that the purpose of the consolidation is “to stabilize the stock price and enhance corporate value by maintaining an appropriate number of shares in circulation.”
Disclosure Plus
SD BIOTECHNOLOGIES CO., LTD. Decides on 5-to-1 Stock Consolidation
Kwon Oh Seok
2026-08-27 17:57:48
Economy
Corporation
IT·Science
Economy
[Market Insight] Interest Rates or Flexibility… U.S. Companies Weigh Private Placement Loans and Syndicated Loans
As the syndicated loan market regains momentum, U.S. companies are crunching the numbers on their financing options. While some companies are switching from private loans to syndicated loans in an eff…
Corporation
Following ADC, ‘XDC’ Draws Attention from Big Pharma… Aptabio Therapeutics Inc. Pursues ‘Platform Deal’
Aptabio Therapeutics Inc.(293780)is exploring opportunities to export its platform technology, led by the aptamer-based drug delivery platform “Apta-DC.” Apta-DC is a technology designed to overcome d…
IT·Science
LG Corp. Sees Widespread Adoption of ChatGPT for Business Use… 30,000 Employees Now Using It
LG CNS (#LG CNS) has secured approximately 30,000 employee users by providing OpenAI’s enterprise artificial intelligence (AI) service, “ChatGPT Enterprise,” to domestic companies.LG Corp. participate…
